Quinazoline and Quinoline Derivatives
Quinazolines and quinolines are nitrogen-containing heterocyclic compounds with aromatic structures that play a key role in the synthesis of drugs with anticancer, antimicrobial, and anti-inflammatory activity. Their derivatives feature structural modifications that optimise bioavailability and selectivity, enabling the development of new active ingredients for various therapeutic applications. These compounds are used in the manufacture of APIs for the treatment of cancer, infections, neurodegenerative diseases, and cardiovascular conditions. Additionally, quinazoline and quinoline derivatives are essential in the research of enzyme inhibitors and the design of innovative bioactive molecules.
At CymitQuimica, we offer high-purity quinazoline and quinoline derivatives for applications in chemical synthesis, pharmaceutical development, and biotechnology.
Found 65580 products of "Quinazoline and Quinoline Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
3-Des(2-methoxyethyl) 3-(1-Methylethyl) Ester Nimodipine
CAS:Controlled Product<p>Impurity Nimodipine EP Impurity B<br>Applications 3-Des(2-methoxyethyl) 3-(1-Methylethyl) Ester Nimodipine (Nimodipine EP Impurity B) can be used in synthetic preparation of dihydropyridinedicarboxylic acid esters by methylimidazolium trifluoroacetate-catalyzed Hantzsch cyclocondensation reaction of oxo-carboxylic acid esters with aldehydes and ammonium acetate. It can also be used as an analyte for analytical study in developing and optimizing a validated isocratic reversed-phase high-performance liquid chromatograhy separation of nimodipine and impurities in tablets using experimental. design methodology. It is an impurity of the drug Nimodipine (N478200).<br>References Avalani, J. R., et al.: J. Chem. Sci., 124, 1091-1096 (2012); Barmpalexis, P., et al.: J. Pharmaceut. Biomed., 49, 1192-1202 (2009)<br></p>Formula:C21H26N2O6Color and Shape:NeatMolecular weight:402.44Desthiazolylmethyloxycarbonyl Ritonavir
CAS:Controlled ProductFormula:C32H45N5O3SPurity:>85%Color and Shape:NeatMolecular weight:579.805-Ethenyl-2-pyrrolidinone
CAS:Controlled Product<p>Impurity Vigabatrin USP Related Compound A<br>Applications Vigabatrin (V253000) impurity. Vigabatrin USP Related Compound A.<br>References Durham, S. et al.: Drug Metab. Dispos. 21, 480 (1993).<br></p>Formula:C6H9NOColor and Shape:Colourless To BrownMolecular weight:111.143-[2-[4-(4-Fluoro-2-hydroxybenzoyl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
CAS:Controlled Product<p>Applications 3-[2-[4-(4-Fluoro-2-hydroxybenzoyl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one is an intermediate used in the synthesis of Bicyclo Risperidone (B382800), which is an impurity of Risperidone (R525000); a combined serotonin (5-HT2) and dopamine (D2) receptor antagonist.<br>References Jannssen, P.A.J., et al.: J. Pharmacol. Exp. Ther., 244, 685 (1988); Gelders, Y.G., et al.: Pharmacopsychiatry, 23, 206 (1990); Green, B.: Curr. Med. Res. Opin., 16, 57 (2000)<br></p>Formula:C23H28FN3O3Color and Shape:NeatMolecular weight:413.491-[1-(4-Chlorobenzoyl)-5-hydroxy-2-methyl-1H-indole-3-acetate]β-D-Glucopyranuronic Acid
CAS:Controlled Product<p>Stability Hygroscopic, Moisture Sensitive<br>Applications 1-[1-(4-Chlorobenzoyl)-5-hydroxy-2-methyl-1H-indole-3-acetate]β-D-Glucopyranuronic Acid is an analog of Indomethacin Acyl-β-D-glucuronide a metabolite of Indomethacin (I641000). Acyl glucuronides have been implicated in the toxicity of many xenobiotics and marketed drugs.<br>References Abid, A., et al.: Biochem. Pharmacol., 50, 557 (1995), Gamage, N., et al.: Toxicol. Sci., 90, 5 (2006), Cerveny, L., et al.: Drug Metab. Dispos., 35, 1032 (2007), Hayeshi, R., et al.: Eur. J. Pharm. Sci., 35, 383 (2008),<br></p>Formula:C24H22ClNO10Color and Shape:NeatMolecular weight:519.89Indomethacin 1-Glycerin Ester
CAS:<p>Applications Indometacin 1-Glycerin Ester was synthesized and evaluated for anti-flammatory activity in the rate paw carrageenin edema essay.<br>References Paris, Gerard. , et al.: J. Med. Chem, 23, 9 (1980)<br></p>Formula:C22H22ClNO6Color and Shape:NeatMolecular weight:431.87Cibenzoline
CAS:Controlled Product<p>Applications Cibenzoline acts as a highly active class I antiarrhythmic agent.<br>References Xie, C. et al.: Handbook. Metab. Pathway. Xenobio., 3, 1110 (2014);<br></p>Formula:C18H18N2Color and Shape:NeatMolecular weight:262.352-Cyano-3-(3-chlorophenylethyl)pyridine
CAS:Controlled ProductFormula:C14H11ClN2Color and Shape:NeatMolecular weight:242.70Lumateperone-d4
CAS:Controlled ProductFormula:C24D4H24FN3OColor and Shape:NeatMolecular weight:397.522N-Methyl Omeprazole-d3 (Mixture of isomers with the methylated nitrogens of imidazole)
CAS:Controlled Product<p>Applications Labelled Omeprazole (O635000) impurity.<br>References Allenmark, S., et al.: Anal. Biochem., 136, 293 (1984), Besancon, M., et al.: J. Biol. Chem., 272, 22438 (1997),<br></p>Formula:C18H18D3N3O3SColor and Shape:NeatMolecular weight:362.462-(4-(Methylsulfonamido)phenyl)acetic Acid
CAS:Controlled Product<p>Applications 2-(4-(Methylsulfonamido)phenyl)acetic Acid acts as a reagent for resiniferatoxin analogs preparation as metabolically stable TRPV1 agonists and potential analgesics. Preparation and structure-activity relationships of 2,6-diaryl-4-(phenacylamino)pyrimidines as selective adenosine A2A antagonists.<br>References Choi, H., et al.: Bioorg. Med. Chem. , 17, 690 (2009); Moorjani, M., et al.: Bioorg. Med. Chem. Lett., 18, 1269 (2008)<br></p>Formula:C9H11NO4SColor and Shape:NeatMolecular weight:229.255-Hydroxy Propranolol Hydrochloride
CAS:Controlled Product<p>Applications A metabolite of Propranolol.<br>References Otton, S., et al.: Br. J. Clin. Pharmacol., 30, 751 (1990), Fujita, S., et al.: J. Pharmacol. Exp. Ther., 264, 226 (1993), Bichara, N., et al.: Drug Metab. Dispos., 24, 112 (1996), Tasaki, T., et al.: J. Biochem., 123, 162 (1998),<br></p>Formula:C16H21NO3·HClColor and Shape:NeatMolecular weight:311.8044-(2-Nitrophenyl)morpholin-3-one
CAS:Controlled Product<p>Applications 4-(2-Nitrophenyl)morpholin-3-one is an intermediate in the synthesis of 4-(2-Aminophenyl)-3-morpholinone (A625985). 4-(2-Aminophenyl)-3-morpholinone is a reagent used in the preparation of various Morpholine based pharmaceuticals.<br>References Mederski, W., et al.: Bioorg. Med. Chem. Lett., 14, 3763 (2004); Roehrig, S., et al.: J. Med. Chem., 48, 5900 (2005)<br></p>Formula:C10H10N2O4Color and Shape:NeatMolecular weight:222.25-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole Hydrochloride
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications An intermediate of 5-Fluoro Risperidone (F595925).<br>References Strupczewski, J.T., et al.: J. Med. Chem., 28, 761 (1985),<br></p>Formula:C12H13FN2O·ClHColor and Shape:NeatMolecular weight:256.70N-Ethyl-N-nitroso-2-propanamine (100 μg/mL in Methanol)
CAS:Controlled ProductFormula:C5H12N2OColor and Shape:ColourlessMolecular weight:116.1616Leflunomide EP Impurity G
CAS:Controlled ProductFormula:C12H12N2O2Color and Shape:NeatMolecular weight:216.24Mosapride-d5
CAS:Controlled Product<p>Applications A labelled selective 5-HT4 receptor agonist. Gastroprokinetic.<br>References Yoshida, N., et al.: Arch. Int. Pharmacodyn. Ther., 300, 51 (1989), Yatera, S., et al.: Japan. Pharmacol. Ther., 21, 21 (1993), Ruth, M., et al.: Aliment Pharmacol. Ther., 12, 35 (1998),<br></p>Formula:C21H20D5ClFN3O3Color and Shape:NeatMolecular weight:426.92Vortioxetine Glucose Adduct
CAS:Controlled Product<p>Applications Vortioxetine Glucose Adduct, is an impurity of Vortioxetine (V766000), a multimodal serotonergic agent that inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT (1,2,3).<br>References Paunovic, A. et al.: ACS Chem. Biol., 12, 132 (2017);<br></p>Formula:C24H32N2O5SColor and Shape:NeatMolecular weight:460.59(S)-4-Phenyl-2-oxazolidinone
CAS:Controlled Product<p>Applications S)-4-Phenyl-2-oxazolidinone is an intermediate for the synthesis and development for cholesterol absorption inhibitor AZD4121.<br>References Soloshonok, V.A., et al.: Tetrahedron. Lett., 46, 1107 (2005); Luo, Y., et al.: Chinese. Chem. Lett., 17, 1551 (2006); Karlsson, S., et al.: Org. Process.Res. Develop., 16, 586 (2012);<br></p>Formula:C9H9NO2Color and Shape:NeatMolecular weight:163.1733Anastrozole EP Impurity E (2-[3-(Cyanodimethylmethyl)-5-hydroxymethylphenyl]-2-methylpropionitrile)
CAS:Controlled Product<p>Impurity Anastrozole EP Impurity E<br>Applications 2-[3-(Cyanodimethylmethyl)-5-hydroxymethylphenyl]-2-methylpropionitrile (Anastrozole EP Impurity E ) is an impurity of Anastrozole (A637425), an aromatase inhibitor which functions as an antineoplastic (1,2). Anastrozole is used in post-menopausal women with advanced breast cancer.<br>References 1. Plourde, P. et al.: Breast Cancer Res Treat. 1994;30(1):103-112. Buzdar, A. et al.: Cancer. 1997 Feb 15;79(4):730-9.<br></p>Formula:C15H18N2OColor and Shape:NeatMolecular weight:242.32(S)-(-)-Tolvaptan
CAS:Controlled Product<p>Applications An enantiomer of Tolvaptan. It is a selective, competitive arginine vasopressin V2 receptor antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).<br>References Paterna, S., et al.: Eur. J. Heart Fail, 2, 305 (2000), Udelson, J., et al.: Circulation, 104, 2417 (2001), Goldsmith, S., et al.: J. Am. Coll Cardiol., 46, 1785 (2005), Schrier, R., et al.: N. Engl. J. Med., 355, 2099 (2006),<br></p>Formula:C26H25ClN2O3Color and Shape:Off White SolidMolecular weight:448.944-Hydroxy Ramelteon
CAS:<p>Applications A metabolite of Ramelteon (R110051)<br></p>Formula:C16H21NO3Color and Shape:Off White SolidMolecular weight:275.343-(5-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzenamine
CAS:Controlled Product<p>Stability Air Sensitive<br>Applications 3-(5-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzenamine is used in the preparation of c-Src and Abl inhibitors based on the scaffold present in Imatinib (G407000), used in the treatment of myelogenic leukemia. It is a COVID19-related research product.<br>References Seeliger, M. et al.: Canc. Res., 69, 2384 (2009); Schindler, T., et al.: Science, 289, 1938 (2000); Drucker, B.J., et al.: N. Engl. J. Med., 344, 1031 (2001)<br></p>Formula:C11H10N3F3Color and Shape:NeatMolecular weight:241.212-(Bromomethyl)-3-nitrobenzoic Acid Methyl Ester
CAS:Controlled Product<p>Applications 2-(Bromomethyl)-3-nitrobenzoic Acid Methyl Ester (cas# 98475-07-1) is a compound useful in organic synthesis.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br></p>Formula:C9H8BrNO4Color and Shape:Off-White To Light YellowMolecular weight:274.07Loratadine-d5
CAS:Controlled Product<p>Applications Loratadine-d5 is the labeled analogue of Loratadine (L469575), a nonsedating-type histamine H1-receptor.<br>References Bruttmann, G., et al.: J. Allergy Clin. Immunol., 83, 411 (1989); Haria, M., et al.: Drugs, 48, 617 (1994)<br></p>Formula:C22H18D5ClN2O2Color and Shape:NeatMolecular weight:387.91rac Methotrimeprazine Sulfoxide
CAS:Controlled Product<p>Applications A metabolite of Methotrimeprazine (M260785).<br>References Haddad, P., et al.: Drugs, 62, 1649 (2002),<br></p>Formula:C19H24N2O2SColor and Shape:NeatMolecular weight:344.471-(4-(4-(tert-Butyl)phenyl)-4-hydroxybutyl)piperidine-4-carboxylic Acid
Controlled ProductFormula:C20H31NO3Color and Shape:NeatMolecular weight:333.465Telmisartan Amide
CAS:<p>Impurity Telmisartan EP Impurity F / Telmisartan Amide<br>Applications An amide impurity of Temisartan (D294250).<br>References Xu, G. et al.: Zhong. Yiyao Gong. Zaz., 40, 714 (2009);<br></p>Formula:C33H31N5OColor and Shape:NeatMolecular weight:513.63Imatinib (Piperidine)-1-oxide
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Imatinib (Piperidine)-1-oxide is an impurity of Imatinib (Gleevec) (G407000). Imatinib impurity C. It is a COVID19-related research product.<br>References Taruns, C., et al.: Bioorg. Chem., 16, 38 (1988), Cohen, M., et al.: Clin. Cancer Res., 8, 935 (2002), Gschwind, H., et al.: Drug Metab. Dispos., 33, 1503 (2005), Peng, B., et al.: Clin. Pharmacokinet., 44, 879 (2005),<br></p>Formula:C29H31N7O2Color and Shape:Light Yellow To YellowMolecular weight:509.607-Ethyl-10-(4-amino-1-piperidino)carbonyloxycamptothecin
CAS:<p>Stability Light Sensitive, Moisture Sensitive, Temperature Sensitive<br>Applications A major metabolite of Irinotecan.<br>References Canal, P., et al.: J. Clin. Oncol., 14, 2688 (1996), Haaz, M., et al.: Cancer Res., 58, 468 (1998), Kehrer, D., et al.: Clin. Cancer Res., 6, 3451 (2000), Hanioka, N., et al.: Xenobiotica, 31, 687 (2001), Satoh, T., et al.: Drug Metab. Dispos., 30, 488 (2002),<br></p>Formula:C28H30N4O6Color and Shape:NeatMolecular weight:518.562,5-Bis-(3,4-dihydroxyphenyl)piperazine Dihydrochloride
Controlled ProductFormula:C16H18N2O4•2(HCl)Color and Shape:BrownMolecular weight:302.3323646Deshydroxymethyl Losartan Trifluoroacetic Acid Salt
CAS:Controlled Product<p>Applications Losartan Impurity C.<br>References Duncia, J.V., et al.: J. Med. Chem., 33, 1312 (1990),<br></p>Formula:C21H21ClN6·C2HF3O2Color and Shape:White To Off-WhiteMolecular weight:506.91Palbociclib
CAS:<p>Applications Palbociclib (also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.<br>References Finn, R., et al.: Breast Cancer Res., 11, 5 (2009);<br></p>Formula:C24H29N7O2Color and Shape:NeatMolecular weight:447.535-(5-Fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic Acid
CAS:Controlled Product<p>Applications Sunitinib intermediate.<br></p>Formula:C16H13FN2O3Color and Shape:NeatMolecular weight:300.28(R)-Phenylephrine β-D-Glucuronide
Controlled Product<p>Stability Hygroscopic<br>Applications A metabolite of Phenylephrine (P320640).<br></p>Formula:C15H21NO8Color and Shape:NeatMolecular weight:343.33Afatinib N-Oxide
Controlled Product<p>Applications Afatinib N-Oxide is a derivative of Afatinib {BIBW 2992) (B377000), an aminocrotonylamino-substituted quinazoline derivative used for treating cancer and diseases of the respiratory tract, lungs, gastrointestinal tract, bile duct, and gallbladder. An anilino-quinazoline that irreversibly inhibits EGFR and HER2 kinase activity.<br>References Ham, J. et al.: Cancer Cell., 29, 159 (2016);<br></p>Formula:C24H25ClFN5O4Color and Shape:White SolidMolecular weight:501.94Afatinib-des(4-dimethylamino-2-en-1-oxo)butyl (Contained ~8.5% Ethanol)
CAS:Formula:C18H16ClFN4O2Color and Shape:NeatMolecular weight:374.8OPC 14714
CAS:Controlled Product<p>Impurity Aripiprazole Impurity<br>Applications A novel antipsychotic agents with dopamine autoreceptor agonist properties. Aripiprazole Impurity<br>References Simpson, G., et al.: Drugs, 1981, 21, 138 (1981), Banno, K., et al.: Chem. Pharm. Bull., 36, 4377 (1988), Momiyama, T., et al.: Life Sci., 47, 761 (1990), Caprathe, B., et al.: J. Med. Chem., 34, 2736 (1991),<br></p>Formula:C23H28BrN3O2Color and Shape:White To Off-WhiteMolecular weight:458.39N-Trityl Candesartan Ethyl Ester
CAS:Controlled Product<p>Applications Candesartan analog as angiotensin II antagonist.<br>References Bakshi, M., et al.: J. Pharm. Biomed. Anal., 28, 1011 (2002),<br></p>Formula:C45H38N6O3Color and Shape:NeatMolecular weight:710.821-Adamantan-d15-amine
CAS:Controlled Product<p>Applications 1-Adamantan-d15-amine is a labeled NMDA-receptor antagonist. Antiviral; antiparkinsonian.<br>References Vernier, V.G., et al; Toxicol. Appl. Pharmacol., 15, 642 (1969); Kirschbaum, J., et al.: Anal. Profiles Drug Subs., 12, 1 (1983)<br></p>Formula:C102H15H2NColor and Shape:White To BeigeMolecular weight:166.344-Fluoro-2-(hydroxymethyl)phenol
CAS:Controlled Product<p>Applications 4-Fluoro-2-(hydroxymethyl)phenol can be used in preparation of naphthyridine derivatives as chemokine receptor antagonists useful in the treatment of pain.<br>References Wang, X., et al.: PCT Int. Appl., WO 2013010453 A1 20130124 (2013)<br></p>Formula:C7H7FO2Color and Shape:NeatMolecular weight:142.1285’-Hydroxyphenyl Carvedilol
CAS:<p>Applications A metabolite of Carvedilol (C184625). It is used in the treatment of hypertension.<br>References Sponer, G., et al.: J. Cardiovasc. Pharmacol., 9, 317 (1987), Fujimaki, M., ET AL.: Xenobiotica, 20, 1025 (1990), Ruffolo, R., et al.: Eur. J. Clin. Pharmacol., 38, S82 (1990), Schaefer, W.H., et al.: Drug Metab. Dispos., 26, 10, 958 (1998),<br></p>Formula:C24H26N2O5Color and Shape:NeatMolecular weight:422.473-O-Benzyl-4,5-O-(1-methylethyldiene)-β-D-fructopyranose
CAS:Controlled Product<p>Applications Intermediate in the preparation of 2,3-Desisopropylidene Topiramate, a metabolite of Topiramate<br></p>Formula:C16H22O6Color and Shape:NeatMolecular weight:310.34Hydroxy Iloperidone-d4
CAS:Controlled Product<p>Applications A hydroxylated labelled metabolite of Iloperidone (I267200).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Mutlib, A., et al.: Drug Metab. Dispos., 23, 951 (1995), Westerink, B., et al.: Eur. J. Pharmacol., 412, 127 (2001),<br></p>Formula:C24H25D4FN2O4Color and Shape:Off White SolidMolecular weight:432.52N-Nitrosomorpholine-13C4
CAS:Controlled ProductFormula:C4H8N2O2Color and Shape:NeatMolecular weight:120.091-Hydroxy-3,4-dihydroquinolin-2(1H)-one
CAS:Controlled ProductFormula:C9H9NO2Color and Shape:NeatMolecular weight:163.175-Methyl-1,3-benzenediacetonitrile
CAS:<p>Impurity Anastrozole 1,3-Dicyanomethyl Impurity<br>Applications 5-Methyl-1,3-benzenediacetonitrile is an Anastrozole intermediate. Anastrozole 1,3-Dicyanomethyl Impurity. Anastrozole is an aromatase inhibitor and used as an antineoplastic.<br>References Plourde, P.V., et al.: Breast Cancer Res. Treat., 30, 103 (1994), Buzdar, A.U., et al.: Cancer, 79, 730 (1997)<br></p>Formula:C11H10N2Color and Shape:NeatMolecular weight:170.21Iproniazid
CAS:Controlled Product<p>Applications Iproniazid is a hydrazine based drug used as an antidepressant. Iproniazid acts as an irreversible and nonselective monoamine oxidase inhibitor.<br>References Fagervall, I. et al.: Biochem. Pharmacol., 35, 1381 (1986); Horita, A.: Princ. Psychopharmacol., 279 (1970); O'Donnell, J.M. et al.: Psychopharmacology, 78, 214 (1982);<br></p>Formula:C9H13N3OColor and Shape:White SolidMolecular weight:179.227,7’-[(1,4-Butanediyl)bis(oxy)]bis-2(1H)quinolinone
CAS:<p>Applications 7,7’-[(1,4-Butanediyl)bis(oxy)]bis-2(1H)quinolinone is an impurity of Brexpiprazole (B677385), which is a drug candidate useful in treatment and prevention of mental disorders including CNS disorders.<br>References Yamashita, H., et al.: PCT Int. Appl., WO 2006112464 A1 20061026 (2006)<br></p>Formula:C22H20N2O4Color and Shape:NeatMolecular weight:376.405rac Cinacalcet-d3 Hydrochloride
CAS:Controlled Product<p>Applications Clinical trial in secondary hyperparathyroidism.<br>References Franceschini N., et al.: Expert Opin. Invest. Drugs, 12, 1413 (2003), Block, G.A., et al.: N. Engl. J. Med. 350, 1516 (2004),<br></p>Formula:C222H3H19F3N·ClHColor and Shape:NeatMolecular weight:396.89Ethyl 3,4-Dihydroxybenzoate
CAS:Controlled ProductFormula:C9H10O4Color and Shape:NeatMolecular weight:182.172,4-Difluorobenzoic Acid
CAS:Controlled Product<p>Applications 2,4-Difluorobenzoic Acid (cas# 1583-58-0) is a compound useful in organic synthesis.<br></p>Formula:C7H4F2O2Color and Shape:NeatMolecular weight:158.10rac O-Acetyl Pseudoephedrine Hydrochloride
CAS:Controlled Product<p>Applications rac O-Acetyl Pseudoephedrine is a racemic O-acetylated analogue of the non-selective adrenergic agonist Pseudoephedrine (P839350).<br>References Snopek, J. et al.: J. Chrom., 438, 211 (1988);<br></p>Formula:C12H17NO2·ClHColor and Shape:WhiteMolecular weight:243.732-Bromomethyl-6-nitrobenzoic Acid Methyl Ester
CAS:Controlled ProductFormula:C9H8BrNO4Color and Shape:Light YellowMolecular weight:274.07Afatinib Impurity AFT-8
CAS:Controlled Product<p>Applications Afatinib Impurity AFT-8 is an impurity of its parent compound Afatinib (A355300), which is an aminocrotonylamino-substituted quinazoline derivative used for treating cancer and diseases of the respiratory tract, lungs, gastrointestinal tract, bile duct, and gallbladder.<br></p>Formula:C24H27ClFN5O4Color and Shape:NeatMolecular weight:503.954Losartan Trityl Ether
CAS:<p>Impurity Losartan EP Impurity I<br>Applications Losartan Trityl Ether (Losartan EP Impurity I) is an impurity of Losartan.<br>References Duncia, J.V., et al.: J. Med. Chem., 33, 1312 (1990),<br></p>Formula:C41H37ClN6OColor and Shape:NeatMolecular weight:665.23Cabergoline
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Cabergoline is an ergot derivative and a dopamine D2-receptor agonist (1,2,3). It inhibits the secretion of prolactin and growth hormone.<br>References (1) Kvernmo, T., et al.: Clin.Ther. 28 1065 (2006)(2) Boutinaud, M., et al.: J Dairy Sci. 99, 5707 (2016)(3) Hutton, J.T., et al.: Neurology, 46, 1062 (1996<br></p>Formula:C26H37N5O2Color and Shape:White To Off-WhiteMolecular weight:451.603-Chloro-N-(3-hydroxyphenyl)propanamide
CAS:Controlled Product<p>Applications 3-chloro-N-(3-hydroxyphenyl)propanamide (cas# 50297-40-0) is a useful research chemical.<br></p>Formula:C9H10NO2ClColor and Shape:NeatMolecular weight:199.63Gabapentin Ethyl Ester Hydrochloride
CAS:Controlled Product<p>Applications Protected Gabapentin (G117250). Amino acid structurally related to γ-Aminobutyric Acid (GABA), designed to cross the blood brain barrier. Used as an anticonvulsant.<br>References Vollmer, K.-O. et al.: Arzneimittel-Forshc., 36, 830 (1986), Saletu, B., et al.: Int. J. Clin. Pharmacol. Ther. Toxicol., 24, 362 (1986)<br></p>Formula:C11H21NO2·ClHColor and Shape:NeatMolecular weight:235.75Paliperidone N-Oxide
CAS:Controlled Product<p>Impurity Paliperidone USP Related Compound D<br>Applications One of the major degradation product of Risperidone in bulk drug and pharmaceutical dosage forms. Paliperidone USP Related Compound D.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Leysen, J., et al.: J. Pharmacol. Exp. Ther., 247, 661 (1988), Huang, M., et al.: Pharm. Drug Dispos., 54, 257 (1993), Smyth, W., et al.: Anal. Bioanal. Chem., 378, 1305 (2004),<br></p>Formula:C23H27FN4O4Color and Shape:NeatMolecular weight:442.48N-Desethyl N-Methyl Rivastigmine
CAS:Controlled Product<p>Impurity Rivastigmine EP Impurity B<br>Applications N-Desethyl N-Methyl Rivastigmine (Rivastigmine EP Impurity B) is an impurity of Rivastigmine (R541000), a brain selective acetylcholinesterase inhibitor. Nootropic.<br>References Rosler, M., et al.: Brit. Med. J., 318, 633 (1999), Enz, A., et al.: Prog. Brain Res., 98, 431 (1993),<br></p>Formula:C13H20N2O2Color and Shape:NeatMolecular weight:236.32Methylphenidate Carboxylic Acid Hydrochloride
CAS:Controlled Product<p>Applications O-Desmethyl Methylphenidate Carboxylic Acid is a derivative of Methylphenidate Hydrochloride (M325880), controlled substance (stimulant). CNS stimulant. Methylphenidate Carboxylic Acid Hydrochloride is a 4:1 Mixture of R533105 (DL-erythro Ritalinic Acid Hydrochloride) and R533110 (DL-threo-Ritalinic Acid Hydrochloride)<br>References Greenblatt, E.N., et al.: J. Pharmacol. Exp. Ther., 131, 115 (1961), Padmanabhan, G.R., Anal. Profiles Drug Subs., 10, 473 (1981), Srinivas, N.R., et al.: Pharm. Res., 10, 14 (1993),<br></p>Formula:C13H17NO2·HClColor and Shape:Off-WhiteMolecular weight:255.745-[1-Hydroxy-2-(2,4,5-trifluorophenyl)ethylidene]-2,2-dimethyl-1,3-dioxane-4,6-dione
CAS:Controlled Product<p>Applications 5-[1-Hydroxy-2-(2,4,5-trifluorophenyl)ethylidene]-2,2-dimethyl-1,3-dioxane-4,6-dione is an impurity of the DPP-IV inhibitor Sitagliptin (S491000).<br>References Ye, F. et al.: Hech. Huax., 18, 767 (2010); Ahn, J.H, et al.: Bioorg. Med. Chem. Lett., 17, 2622 (2007);<br></p>Formula:C14H11F3O5Color and Shape:NeatMolecular weight:316.23Perampanel-d5 (1.0mg/ml in Acetonitrile)
CAS:Controlled ProductFormula:C23D5H10N3OColor and Shape:ColourlessMolecular weight:354.42Desalkyl Ebastine-d5
CAS:Controlled Product<p>Applications A labelled metabolite of Ebastine.<br>References Wiseman, L., et al.: Drugs, 51, 260 (1996), Takanori, H., et al.: Drug Metab. Dispos., 26, 566 (1998), Moss, A., et al.: Clin. Exp. Allergy 1999, 29, 200 (1999), Simons, F., et al.: Clin. Pharmacokinet., 36, 329 (1999), Hashizume, T., et al.: J. Pharmacol. Exp. Theor., 300, 298 (2002),<br></p>Formula:C18H16D5NOColor and Shape:NeatMolecular weight:272.4CP-690550 N-Hydroxyl
CAS:Controlled Product<p>Impurity CP-690550 Impurity<br>Applications CP-690550 N-Hydroxyl is an impurity of CP-690550 (C781350), a pyrrolo[2,3-d]pyrimidine derivative, as Janus kinase inhibitor for treatment of rheumatoid arthritis.<br>References Sheiner, L., et al.: Clin. Pharmacol. Ther., 25, 358 (1979); Dayneka, N., et al.: J. Pharmacokin. Biopharm., 21, 457 (1993); Changelian, P., et al.: Science, 302, 875 (2003); Lee, H., et al.: Clin. Pharmacol. Ther., 73, 348 (2003); Hutmacher, M., et al.: J. Clin. Pharmacol., 47, 238 (2007)<br></p>Formula:C16H20N6O2Color and Shape:NeatMolecular weight:328.369N-Denitroso-N’-nitroso Lomustine-d4
CAS:Controlled ProductFormula:C9D4H12ClN3O2Color and Shape:NeatMolecular weight:237.724-Oxo-1,4-dihydroquinoline Carboxylic Acid
CAS:Controlled Product<p>Applications 4-Oxo-1,4-dihydroquinoline Carboxylic Acid is a novel HIV-1 integrase strand transfer inhibitor.<br>References Shinkai, H. et al.: Antivir. Drugs. 197 (2011); Liao, C. et al.: ChemMedChem., 5, 1053 (2010);<br></p>Formula:C10H7NO3Color and Shape:NeatMolecular weight:189.17N-(S)-Glycidylphthalimide
CAS:Controlled Product<p>Applications N-(S)-Glycidylphthalimide is a phthalimide derivative used as an intermediate in the preparation of the antibiotic Linezolid (L466500).<br>References Rajesh, T. et al.: Pharm. Chem., 3, 168 (2011);<br></p>Formula:C11H9NO3Color and Shape:WhiteMolecular weight:203.194-(Trifluoromethoxy)aniline
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications 4-(Trifluoromethoxy)aniline is used in the synthesis of anticancer agents and antitumor medicaments. Also, its an intermediate in the production of labelled Riluzole (R510000), a neuroprotective agent. Modulates glutamatergic transmission. A glutamate release inhibitor. An anticonvulsant.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Cilibrizzi, A., et al.: J. Med. Chem., 52, 5044 (2009), Verhaeghe, P., et al.: Bioorg. Med. Chem., 17, 4313 (2009), Chandregowda, V., et al.: Eur. J. Med. Chem., 44, 3046 (2009), Wahl, F., et al.: Eur. J. Pharmacol., 230, 209 (1993) Bensimon, G., et al.: N. Engl. J. Med., 330, 585 (1994); Piras, S. et al.: Eur. j. Med. Chem., 75, 169 (2014); Vyas, V. et al.: Eur. J. Med. Chem., 82, 385 (2014);<br></p>Formula:C7H6F3NOColor and Shape:NeatMolecular weight:177.12Atazanavir-d9
CAS:Controlled Product<p>Applications Atazanavir-d9 is the deuterated analog of Atazanavir (A790051), a azapeptide HIV protease inhibitor derivative. Atazanavir have been investigated as potential treatment of human immunodeficiency virus (HIV) and for anticancer purposes.<br>References Musial, B.L., et al.: Am. J. Health Syst. Pharm., 61, 1365 (2004), Wood, R., et al.: J. Acquir. Immune Defic. Syndr., 36, 684 (2004),<br></p>Formula:C382H15H37N6O7Color and Shape:NeatMolecular weight:719.95Hydrolyzed Pomalidomide M10
CAS:Controlled Product<p>Applications Hydrolyzed Pomalidomide M10 is an impurity of pomalidomide (P688200), which is a thalidomide derivative, a potent inhibitor of TNF-α production. It is an antiinflammatory and antitumor agent used in the treatment of multiple myeloma.<br>References Ruchelman, A. et al.: Bioorg. Med. Chem. Lett., 23, 360 (2013); Latif, T. et al.: Exp. Hematol. Oncol., 1, 27 (2012); Man, H. et al.: Bioorg. Med. Chem. Lett., 13, 3415 (2003); Muller, G. et al.: Bioorg. Med. Chem. Lett., 9, 1625 (1999)<br></p>Formula:C13H13N3O5Color and Shape:NeatMolecular weight:291.26Verapamil Ethyl Methanethiosulfonate, Bromide
CAS:Controlled Product<p>Applications An analog of Verapamil. P Glycoprotein drug binding domain verapamil methanethiosulfonate. Useful for mapping the pore region of L-type calcium channels and Kv1.3 potassium channels.<br>References Loo, T., et al.: J. Biol. Chem., 270, 843 (1995), Sharom, F., et al.: J. Membr. Biol., 160, 161 (1997), Kim, R., et al.: J. Clin. Invest., 101, 289 (1998), Lee, C., et al.: Biochemistry., 37, 3594 (1998),<br></p>Formula:C30H45N2O6S2·BrColor and Shape:NeatMolecular weight:673.72Ezetimibe-13C6
CAS:Controlled Product<p>Applications Labelled Ezetimibe (E975000), an antihyperlipoproteinemic. A Cholesterol absorption inhibitor.<br>References van Heek, M., at al.: J. Pharmacol. Exp. Ther., 283, 157 (1997), van Heek, M., at al.: Brit. J. Pharmacol., 129, 1748 (2000)<br></p>Formula:C1813C6H21F2NO3Color and Shape:NeatMolecular weight:415.383-[2-[4-(6-Fluoro-2-benzoxazolyl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one (Risperidone Impurity)
CAS:Controlled ProductFormula:C23H27FN4O2Color and Shape:NeatMolecular weight:410.48Manidipine
CAS:Controlled Product<p>Applications A dihydropyridine calcium channel blocker. Antihypertensive.<br>References Meguro, K., et al.: Chem. Pharm. Bull., 33, 3787 (1985), Mizuno, K., et al.: Curr. Ther. Res., 52, 248 (1992)<br></p>Formula:C35H38N4O6Color and Shape:Off White PowderMolecular weight:610.70(E,Z)-Tamoxifen-d5 N-β-D-Glucuronide (~90%)
CAS:Controlled Product<p>Applications Α labelled metabolite of Tamoxifen (T006000).<br>References Sun, D., et al.: Breast Cancer Res., 8(4), (2006), Zheng, Y., et al.: Drug Metab. Dispos., 35, 1942 (2007),<br></p>Formula:C32H33D5NO7Purity:~90%Color and Shape:NeatMolecular weight:553.681-[6-(2-propenyl)-ergoline-8β-carbonyl]-3-methyl-perhydropyrimidine-2-one Methanolate
Controlled ProductFormula:C24H32N4O3Color and Shape:NeatMolecular weight:424.54N-(4-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine
CAS:Controlled Product<p>Applications Intermediate in the preparation of Imatinib impurities. It is a COVID19-related research product.<br></p>Formula:C16H15N5Color and Shape:NeatMolecular weight:277.32Nilotinib 3-Imidazolyl N-oxide
CAS:Controlled Product<p>Applications 4-Methyl-3-(4-pyridin-3-yl)pyrimidin-2-yl]amino-N-(5-(3-oxo-4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamine is an impurity compound of Nilotinib (N465300), useful in the treatment of chronic myelogenous leukemia. It is a COVID19-related research product.<br>References Wei-Sheng H., et al.: Synthesis, 14, 2121 (2007); Corbin, A., et al.: J. Biol. Chem., 277, 32214(2002), Golemovic, M., et al.: Clin. Cancer Res., 11, 4941 (2005), Gleixner, K., et al.: Blood, 107, 752 (2006), Nicolini, F., et al.: Leukemia, 20, 1061 (2006),<br></p>Formula:C28H22F3N7O2Color and Shape:NeatMolecular weight:545.52Zomepirac Sodium Salt
CAS:Controlled Product<p>Applications Zomepirac is an analgesic, anti-inflammatory drug.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Sofia, R., et al.: Pharmacol. Res. Commun., 11, 179 (1979), Grindel, J.M., et al.: Drug Metab. Dispos., 8, 343 (1980), Steele, C.E., et al.: Curr. Med. Res. Opin., 8, 382 (1983),<br></p>Formula:C15H13ClNO3·NaColor and Shape:Off White SolidMolecular weight:313.71Methyl 3,4,5-Tris(benzyloxy)benzoate
CAS:Controlled Product<p>Applications Intermediate in the production of Gallic Acid derivatives.<br>References Dodo, K., et al.: Bioorg. Med. Chem., 16, 7975 (2008), Dodo, K., et al.: Chem. Pharm. Bull., 57, 190 (2009),<br></p>Formula:C29H26O5Color and Shape:NeatMolecular weight:454.51Valsartan Decarboxylic Acid
CAS:Controlled ProductFormula:C23H29N5OColor and Shape:NeatMolecular weight:391.5093N-(1-Carboxy-3-phenylpropyl)-S-lisinopril (Mixture of diastereomers)
CAS:Controlled Product<p>Applications N-(1-Carboxy-3-phenylpropyl)-S-lisinopril (Mixture of diastereomers) is an impurity of lisinopril (L468985), an orally active angiotensin-converting enzyme (ACE) inhibitor.<br>References Shinde, V., et. al.: J. Pharm. Biomed. Anal., 43, 381 (2007); Goa, K.L., et al.: Drugs, 52, 564 (1996), Chaturvedi, N., et al.: Lancet, 351, 28 (1998)<br></p>Formula:C31H41N3O7Color and Shape:NeatMolecular weight:567.679-Acridinecarboxylic acid
CAS:Controlled Product<p>Applications 9-Acridinecarboxylic acid is used in the synthesis of short DNA-binding peptides.<br></p>Formula:C14H9NO2Color and Shape:YellowMolecular weight:223.23(D,L)-erythro-α-Phenyl-2-piperidineacetamide
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Intermediate in the preparation of D-threo-Methylphenidate (Ritalin)<br></p>Formula:C13H18N2OColor and Shape:NeatMolecular weight:218.29Losartan Carboxylic Acid Acyl-β-D-Glucuronide, 90%
CAS:Controlled Product<p>Applications A metabolite of Losartan (L470500).<br></p>Formula:C28H29ClN6O8Purity:90%Color and Shape:NeatMolecular weight:613.023-Bromo-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridin-2-one
CAS:Formula:C16H11BrN2OColor and Shape:Light Brown To Dark BrownMolecular weight:327.18rac-Bromo-Descyanobicalutamide
Controlled Product<p>Applications Descyano-Bromo-Bicalutamide is related to Bicalutamide(B382000). A non-steroidal androgen receptor antagonist that binds the androgen receptor and prevents its activation<br>References Tucker, H., et al.: J. Med. Chem., 31, 954 (1988), Cockshott, I.D., et al.: Eur. Urol., 18, Suppl. 3, 10 (1990)<br></p>Formula:C17H14BrF4NO4SColor and Shape:NeatMolecular weight:484.26Haloperidol Octanoate
CAS:Controlled ProductFormula:C29H37ClFNO3Color and Shape:NeatMolecular weight:502.063-Amino-5-chloro Salicylic Acid Methyl Ester
CAS:<p>Applications Intermediate in the preparation of Azasetron.<br>References Kawakita, T., et al.: Chem. Pharm. Bull., 40, 624 (1992),<br></p>Formula:C8H8ClNO3Color and Shape:NeatMolecular weight:201.61N,N'-bis(2,6-Dimethylphenyl)-1,4-piperazinediacetamide
CAS:Controlled Product<p>Impurity Ranolazine USP Related Compound D<br>Applications N,N'-bis(2,6-Dimethylphenyl)-1,4-piperazinediacetamide is an intermediate of Ranolazine (R122500), an anti-ischemic agent which modulates myocardial metabolism. Ranolazine is also known to exert antianginal activities.<br>References Sampath, A., et al.: Org. Proc. Rsch. Dev., 16, 748 (2012); Chaitman, B.R., et al.: J. Am. Coll. Cardial., 43, 1375 (2004); McCormack, J.G., et al.: Gen. Pharmacol., 30, 639 (1998); Schofield, J.A.H., et al.: Expert Opin. Invest. Drugs, 11, 117 (2002)<br></p>Formula:C24H32N4O2Color and Shape:NeatMolecular weight:408.54(6S)-N6-[3-[[(6S)-2-Amino-4,5,6,7-tetrahydro-6-benzothiazolyl]amino]-1-ethyl-2-methylpropyl]-4,5,6,7-tetrahydro-2,6-benzothiazolediamine
CAS:<p>Stability Hygroscopic<br>Applications (6S)-N6-[3-[[(6S)-2-Amino-4,5,6,7-tetrahydro-6-benzothiazolyl]amino]-1-ethyl-2-methylpropyl]-4,5,6,7-tetrahydro-2,6-benzothiazolediamine can be obtained from (-)-2-Amino-6-propionamido-tetrahydrobenzothiazole (A628150) and is the byproduct of process for the preparation of pramipexole and salts thereof by reductive amination of (diamino)tetrahydrobenzothiazole with propanal. It is also a Pramaxo Impurity C.<br>References Deo, K., et al.: Indian Pat. Appl. (2015), IN 2013MU02843 A<br></p>Formula:C20H32N6S2Purity:>80%Color and Shape:NeatMolecular weight:420.63834,6-Dichloro-5-nitro-2-(propylthio)pyrimidine
CAS:<p>Stability Unstable in DMSO Solution<br>Applications 4,6-Dichloro-5-nitro-2-(propylthio)pyrimidine is used as a reactnat in the synthesis of carba-nucleosides as potent antagonists of ADP purinergic receptor P2Y12 on human platelets.<br>References Ye, H., et al.: ChemMedChem, 3, 732 (2008);<br></p>Formula:C7H7Cl2N3O2SColor and Shape:NeatMolecular weight:268.120Dasatinib-d8 N-Oxide
CAS:Controlled Product<p>Applications The labelled oxidative metabolite of Dasatinib (M5 metabolite). It is a COVID19-related research product.<br>References Cashman, J.R., et al.: Chem. Res. Toxicol., 8, 165 (1995), Aasmoe, L., et al.: Toxicol. Appl. Pharmacol., 150, 86 (1998), Galetin, A., et al.: J. Pharmacol. Exp. Ther., 314, 180 (2005), Christopher, L.J., et al.: Drug Metab. Dispos., 36, 1357 (2008),<br></p>Formula:C22H18D8ClN7O3SColor and Shape:NeatMolecular weight:512.05Moclobemide N-Oxide
CAS:<p>Applications Moclobemide N-Oxide is a metabolite of Moclobemide (M481000), a reversible monoamine oxidase inhibitor.<br>References Plenis, A., et. al.: Biomed. Chrom., 21, 958 (2007); Rakic, A., et. al.: J. Pharmaceut. Biomed. Anal., 43, 1416 (2007); Wiesel, F.A., et al.: Eur. J. Clin. Pharmacol., 28, 89 (1985), Burkard, W.P., et al.: J. Pharmacol. Exp. Ther., 248, 391 (1989)<br></p>Formula:C13H17ClN2O3Color and Shape:NeatMolecular weight:284.74R-(-)-N-Demethyl Deprenyl
CAS:Controlled Product<p>Applications A metabolite of Deprenyl (D288641) (Selegiline).<br>References Dyck, L., et al.: Drug Metab. Dispos., 29, 1156 (2001), Damaj, M., et al.: J. Pharmacol. Exp. Ther., 320, 250 (2007),<br></p>Formula:C12H15N·ClHColor and Shape:NeatMolecular weight:209.72Rivaroxaban N-Hydrolyse N-5-Chlorothiophene-2-carbaldehyde
CAS:<p>Stability Hygroscopic<br>Applications Rivaroxaban N-Hydrolyse N-5-Chlorothiophene-2-carbaldehyde is an intermediate in synthesizing Rivaroxaban Pseudodimer (R538015), which is an impurity of Rivaroxaban (R538000), a novel antithrombotic agent. A highly potent and selective, direct FXa inhibitor.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Ansell, J., et al.: Drugs, 64, 1 (2004); Eriksson, B., et al.: J. Thromb. Haemost., 3, 103 (2005); Kubitza, D., et al.: Clin. Pharmacol. Ther., 78, 412 (2005)<br></p>Formula:C24H21Cl2N3O7S2Color and Shape:NeatMolecular weight:598.48
![3-[2-[4-(4-Fluoro-2-hydroxybenzoyl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FF591878.webp&w=3840&q=75)
![1-[1-(4-Chlorobenzoyl)-5-hydroxy-2-methyl-1H-indole-3-acetate]β-D-Glucopyranuronic A…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FC429115.webp&w=3840&q=75)
![Anastrozole EP Impurity E (2-[3-(Cyanodimethylmethyl)-5-hydroxymethylphenyl]-2-methylpropionitrile)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FA637428.webp&w=3840&q=75)
![7,7’-[(1,4-Butanediyl)bis(oxy)]bis-2(1H)quinolinone](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FB677435.webp&w=3840&q=75)
![5-[1-Hydroxy-2-(2,4,5-trifluorophenyl)ethylidene]-2,2-dimethyl-1,3-dioxane-4,6-dione](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FH971700.webp&w=3840&q=75)
![3-[2-[4-(6-Fluoro-2-benzoxazolyl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FF588505.webp&w=3840&q=75)
![1-[6-(2-propenyl)-ergoline-8β-carbonyl]-3-methyl-perhydropyrimidine-2-one Methanolate](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FP768815.webp&w=3840&q=75)
![(6S)-N6-[3-[[(6S)-2-Amino-4,5,6,7-tetrahydro-6-benzothiazolyl]amino]-1-ethyl-2-methylpropyl]-4,5,6…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FN900580.webp&w=3840&q=75)
